Fair value · Bioceres Crop Solutions Corp. (BIOX) · updated 2026-11-19 · from annual report FY2026
Bioceres Crop Solutions trades at $0.20. That price implies a 54.3% free-cash-flow yield.
Cboe · delayed 15 min · as of 20:05 ET
Are those assumptions reasonable? Use BIOX’s filed growth history and the AI chat to decide, then set your own inputs below — the range you build is yours.
What the price implies
- FCF yield
- 54.3%
free cash flow ÷ enterprise value (1.8× EV/FCF)
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings. This price: Cboe · delayed 15 min · as of 20:05 ET.
Inputs come from the FY2026 annual report filed (accession 0001104659-26-120726); set your own on the sliders below. Research, not investment advice.
The filing behind these numbers
Bioceres Crop Solutions Corp.- Revenue
- $238.3M
- Diluted EPS
- $-4.06
- Free cash flow
- $65.0M
- operating cash flow − capital expenditure
- Diluted shares
- 63.6M
- weighted average
annual report FY2026 · fiscal year ended 2026-06-30 · filed 2026-10-30 · accession 0001104659-26-120726
Open this filing on sec.govNeed BIOX data in your own agent or pipeline?
The valuation data behind this page — DCF fair value, margin of safety, PE vs industry, analyst estimates — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.